Equity Shares Allotment9 April 2026 at 01:31 pm
Fredun Pharmaceuticals Allots 40,000 Equity Shares to Promoter upon Conversion of Warrants
AI Summary
Fredun Pharmaceuticals Ltd. has allotted 40,000 Equity Shares to promoter Mrs. Daulat Nariman Medhora upon conversion of warrants. The warrants were allotted on preferential basis on December 29, 2025, and the warrant holders have paid the balance consideration of ₹ 3,75,00,000/-. The Equity Shares will rank pari passu with the existing Equity Shares of the Company.
Key Highlights
- Allotment of 40,000 Equity Shares to promoter
- Warrants allotted on preferential basis on December 29, 2025
- Balance consideration of ₹ 3,75,00,000/- paid by warrant holders
- Equity Shares to rank pari passu with existing Equity Shares
- Allotment in dematerialized form
FREDUNPharmaceuticals
Fredun Pharmaceuticals LtdPrice Impact